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July 12, 2011:311–5of even minor troponin elevations (5). Maybe the time for
diagnostic criteria revision is coming.
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Reply
The apparent paradox of discrepant results of biomarker measure-
ments after percutaneous coronary intervention (PCI) has added
further confusion to our limited understanding of myocardial
injury that occurs during revascularization. In patients with com-
plex multivessel disease, this myocardial injury occurs equally
during either coronary artery bypass graft surgery or PCI despite
contemporary procedural technique (1). Myocardial injury during
PCI may be either adjacent, caused by occlusion of small side
branches during stent implantation, or downstream/distal, caused
by embolized atheroma/thrombotic material (2).
Our recent data suggest that higher levels of troponin elevation
orrelate well with creatine kinase-myocardial band (CK-MB)
levation after PCI (3), and we have previously shown that these
iomarker elevations reflect areas of myocardial infarction demon-
trable with cardiac magnetic resonance imaging (4). However, in
atients with lower levels of troponin elevation after PCI, CK-MB
s unlikely to be elevated. In these patients, there is limited
vidence of systemic inflammation and no evidence of myocardial
nfarction on magnetic resonance imaging.
When undertaking analyses of the clinical implication of these
maller troponin elevations after PCI, we should exclude the
otential bias of the higher troponin elevations, which, in my
pinion, have a clear prognostic consequence. Recently, Cavallini
t al. (5) have confirmed that smaller elevations of troponin after
CI (when CK-MB is normal) are principally a reflection of the
atient’s baseline risk profile and that the prognostic impact ismarginal. In my opinion, this particular clinical scenario of normal
CK-MB with small troponin rise would be best categorized in the
less emotive category “procedural necrosis” rather than “myocardial
infarction.”
Consequently, I agree with the recommendation of Lippi and
Cervellin that a change in the arbitrary threshold for procedural
infarction when measuring troponin after PCI would be useful.
This change in the “universal definition” may allow us to steer
safely between Scylla and Charybdis toward a better understanding
of revascularization injury and perhaps, ultimately, to the destina-
tion of abolishing it.
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“Universal Definition”
Methodology and
Conclusions Are a Concern
We congratulate Lim et al. (1) on their recent paper assessing this
area relevant to clinical practice, especially in light of sensitive
cardiac troponin (cTn) assays. However, we have important
concerns over the methodology and conclusions.
First, it seems inappropriate to use an insensitive test, late
gadolinium enhancement cardiac magnetic resonance (CMR), as a
gold standard diagnosis, to compare a sensitive test, cTn, with a
moderately sensitive test, creatine kinase-myocardial band (CK-
